Skip to main content
. 2020 Mar 10;12(3):638. doi: 10.3390/cancers12030638
mCRC metastatic colorectal cancer
TT targeted therapy
LOM only colorectal cancer metastases
MTD multi-disciplinary team
CT-scan contrast-enhanced computed tomography
MRI magnetic resonance imaging
HME high c-MYC expression
LME low c-MYC expression
PFS progression free survival
OS overall survival
miR miRNA
NCM normal colonic mucosa